Automated – Consistent – Reliable – Fast
Our automated selection systems using the latest high-throughput technologies allow us to offer rapid development of aptamers with unparalleled precision and accuracy.
We offer a staged platform for aptamer development, offering the user explicit control over the process.
Phase 1 – Target Preparation & Validation – 2 weeks
Aptamer Group allows confirmation of whether a high-affinity aptamer will be able to be raised to your target within two weeks of the project beginning.
Phase 2 – Aptamer Population Selection – 5-7 weeks
Using our high-throughput platform, we aim to complete aptamer selection in as little as 5 weeks.
Phase 3 – Selectivity Profiling (Characterisation) – 2 weeks
Aptamers produced are profiled using functional assays in the appropriate buffer/matrix
Phase 4 – Individual Aptamer Identification – up to 8 weeks
This process converts a ‘polyclonal’ aptamer mix into a list of ‘monoclonal’ aptamers. Individual aptamers are assessed for target affinity.